FIGURE 2.
Kaplan‐Meier curves of the intent‐to‐treat (ITT) population in the tivantinib group (blue line) vs the placebo group (yellow line). A, Progression‐free survival (PFS) based on independent radiological committee. B, Overall survival (OS)
Kaplan‐Meier curves of the intent‐to‐treat (ITT) population in the tivantinib group (blue line) vs the placebo group (yellow line). A, Progression‐free survival (PFS) based on independent radiological committee. B, Overall survival (OS)